•
Dec 31, 2024
McKesson Q3 2025 Earnings Report
Expected Revenue:$96.1B
+23.3% YoY
Expected EPS:$8.6
+22.2% YoY
Key Takeaways
McKesson's third quarter revenues increased by 18% to $95.3 billion, driven by growth in the U.S. Pharmaceutical segment. Adjusted Earnings per Diluted Share increased by 4% to $8.03, and the company raised its full year Adjusted EPS guidance range to $32.55 to $32.95.
Consolidated revenues increased by 18% to $95.3 billion.
Earnings per diluted share increased to $6.95.
Adjusted Earnings per Diluted Share increased by 4% to $8.03.
McKesson raised and narrowed fiscal 2025 Adjusted Earnings per Diluted Share guidance to $32.55 to $32.95.
McKesson
McKesson
McKesson Revenue by Segment
Forward Guidance
McKesson is raising and narrowing fiscal 2025 Adjusted Earnings per Diluted Share guidance to $32.55 to $32.95 from the previous range of $32.40 to $33.00.